ExcellGene SA
Jean Troyon is a skilled professional with extensive experience in the biopharmaceutical industry. As a Program Officer at Excellgene SA since November 2020, Jean leads complex client projects and internal programs related to biosimilar development and the scale-up of biologics. Previously, as a Research Associate, Jean directed the development of CHO cell lines and production processes. Prior roles include QA Officer positions at Quotient Limited and UCB, where responsibilities encompassed management of non-conformance and corrective action processes, design control, and validation support. Jean began a career in research during an internship at the Ecole polytechnique fédérale de Lausanne, contributing to scientific publications. Educational qualifications include a Master's degree in Chemical Engineering and Biotechnology from EPFL, along with a Bachelor's degree from the same institution and an Erasmus exchange at Karlsruhe Institute of Technology.
ExcellGene SA
Looking for a trusted partner in the development of cell lines and manufacturing processes? Look no further. With over 20 years of experience, we specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus). We have a proven track record of expressing all types of proteins, including bi-specific mAb, Fc-fusions, viral proteins, cytokines, and more. Our team of scientists is ready to support your project from start to finish, including process development, analytical methods, scale-up, tox-batches, and Master Cell Banking. At our company, we pride ourselves on our commitment to quality and customer satisfaction. Contact us today to see how we can help you achieve your goals and be your trusted partner in cell line and process development.